Company profile
Tenon Medical, Inc.
NASDAQ: TNON · Healthcare · Medical - Devices
#724 of 1,418 Healthcare companies by revenue67th-percentile growth
EA Score
35DFH 36DQ 23GM 61SS 31
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ listing tenure, return on equity
Methodology →Revenue TTM
$4.6M
Rev growth YoY (TTM)
+40.6%
Net income (FY)
-$12.6M
Employees
26
as of 2026-08-25
Market cap
$3.1M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$3.9M$3.9M2025
Net income-$12.6M-$12.6M2025
Operating income-$12.8M-$12.8M2025
Total assets$10.8M$10.8M2025
Liabilities$5.7M$5.7M2025
Equity$5.0M$5.0M2025
Revenue trend
FY2022 – FY2025 · USD
FY22
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Other Operating100%
By geography
Not disclosed.
The read
What is Tenon Medical, Inc.’s revenue?
Tenon Medical, Inc. booked $3.9M in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a -318.4% net margin.
Peers · Healthcare
Hemagen Diagnostics, Inc.——CG Oncology Inc.47DCervoMed Inc.42DNovaBridge Biosciences36DTarget Group Inc.46DEVIO, Inc.——Neighbors
Santa Clara →Key facts
CEOSteven Foster
SectorHealthcare
IndustryMedical - Devices
HeadquartersLos Gatos, CA
ExchangeNASDAQ: TNON
Employees26
IPO date2022-04-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.